# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: John F. Kennedy (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML023-SYN-TD
- Date: 1948-04-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harlan Prescott, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Six-week review after starting levothyroxine. **S**

## History of present illness

Mr. Kennedy returns six weeks after starting levothyroxine 50 mcg, which he takes each morning before breakfast. The morning slowness and feeling cold have gone, and he has no palpitations, tremor or sweating. He takes hydrocortisone 10, 5 and 5 mg and fludrocortisone 0.1 mg without missed doses and has had no illness. He has finished his course of physical therapy and keeps up the home program; he swims three or four times a week and wears the brace only on long journeys. He rarely needs acetaminophen. **S**

| Element | Detail |
|---|---|
| Levothyroxine | 50 mcg daily for six weeks; taken correctly |
| Symptoms | No slowness or cold; no palpitations or tremor |
| Back | Physical therapy finished; home program and swimming; Oswestry 18% |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight up 1.6 kg |
| Cardiovascular | Negative | No palpitations or lightheadedness |
| Endocrine | Negative | No cold or heat intolerance, tremor, or sweating |
| Musculoskeletal | Positive | Mild back stiffness after long sitting |

4 systems reviewed. **S**

## Current medications

- Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking **S**
- Hydrocortisone 5 mg oral tablet, one tablet by mouth at noon and one at 4 pm **S**
- Fludrocortisone 0.1 mg oral tablet, one tablet by mouth once daily **S**
- Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times a day as needed for back pain **S**
- Levothyroxine 50 mcg oral tablet, one tablet by mouth each morning on an empty stomach **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 70.6 kg; BMI 21.1 kg/m². All vital signs are synthetic.

Sodium: 140 mmol/L; Potassium: 4.2 mmol/L; TSH: 3.1 mIU/L; Free T4: 1.2 ng/dL; Oswestry Disability Index: 18. All results are synthetic.

## Change since baseline

- Sodium: 134 mmol/L (low) at baseline, 140 mmol/L at this visit **S**
- Potassium: 5.2 mmol/L (high) at baseline, 4.2 mmol/L at this visit **S**
- TSH: 7.4 mIU/L (high) at baseline, 3.1 mIU/L at this visit **S**
- Free T4: 1 ng/dL at baseline, 1.2 ng/dL at this visit **S**
- Oswestry Disability Index: 32 at baseline, 18 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 70.6 kg; blood pressure 120/76 seated, pulse 72 and regular |
| Neck | Thyroid slightly firm, not enlarged |
| Neurological | No tremor |
| Back | Forward flexion to mid-shin; no tenderness |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Autoimmune hypothyroidism on levothyroxine** (E06.3). TSH 3.1 mIU/L and free T4 1.2 ng/dL six weeks after starting: in target, with symptoms gone. **S**
   - Continue levothyroxine 50 mcg.
   - TSH in six months, then yearly.
2. **Primary adrenal insufficiency (autoimmune Addison's disease)** (E27.1). Well replaced; sodium 140 and potassium 4.2 mmol/L. Blood pressure was taken seated only today. **S**
   - Continue the same doses.
   - Lying and standing blood pressure at the next visit.
3. **Chronic low back pain after lumbar disc surgery** (M96.1). Oswestry 18%, mild disability: the six-month goal is met early. **S**
   - Continue the home program and swimming.
   - Brace only for long journeys.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, and signs of under- or over-replacement | Every visit | Completed today | Weight 70.6 kg; no signs of under- or over-replacement |
| Examination | Blood pressure lying and standing | Every visit | Deferred | Missed: only a seated blood pressure (120/76) was taken. No harm resulted: he had no lightheadedness, sodium and potassium were normal, and there was no postural drop when it was next measured at the preventive visit. Corrective action: lying and standing blood pressure added to the visit template for adrenal insufficiency |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | After any fludrocortisone change, then at least yearly | Completed today | Sodium 140, potassium 4.2 mmol/L |
| Laboratory | Plasma renin activity | After any fludrocortisone change, then at least yearly; aim for the upper normal range | Up to date | In range at the last check; next at the nine-month review |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Rules reviewed; kit, card and medical ID with him |
| Laboratory | TSH and free T4 | 4 to 8 weeks after starting or changing levothyroxine, at 6 months once stable, then yearly | Completed today | Six weeks after starting levothyroxine: TSH 3.1 mIU/L, free T4 1.2 ng/dL |
| Medication safety | Levothyroxine: timing, interactions, and signs of over-replacement | At each thyroid review | Completed today | Taken correctly; no palpitations, tremor or weight loss |
| Laboratory | Other associated autoimmune disease: vitamin B12, A1c, and celiac serology | At diagnosis, then yearly or with symptoms | Up to date | Normal at intake; next yearly |
| Survey | Oswestry Disability Index | Each back pain review | Completed today | 18%, from 26% |
| Self-management | Exercise therapy, physical therapy, and brace use | Home program after the course of physical therapy | Completed today | Course finished; home program and swimming; brace for long journeys only |
| Medication safety | Analgesic use | Every visit | Completed today | Acetaminophen rarely; no NSAID or opioid |

## Goal progress

- No adrenal crisis and no emergency admission through nine months. In progress; target 1948-10-19. **S**
- Hydrocortisone at the lowest dose that keeps him well, within 15 to 25 mg a day, with his weight back toward his usual 72 kg and no signs of over-replacement. In progress; target 1948-10-19. **S**
- Sodium and potassium normal, renin in the upper normal range, and no postural drop in blood pressure by the six-week review. Outcome by 1948-03-09: Sodium 139, potassium 4.4 mmol/L; renin 2.6 ng/mL/h; no postural drop. **S**
- He can state the sick-day rules and give the emergency injection by the two-week visit. Outcome by 1948-01-26: Stated the rules and gave a practice injection on a trainer. **S**
- Oswestry Disability Index below 20% by three months, with the brace used only for long travel. Outcome by 1948-04-20: Oswestry 18% at three months; brace used only on long journeys. **S**

## Guideline basis

- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016), Endocrine Society (Journal of Clinical Endocrinology and Metabolism)
- Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014), American Thyroid Association (Thyroid)
- Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017), American College of Physicians (Annals of Internal Medicine)
- American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023), American College of Gastroenterology (American Journal of Gastroenterology)
- CMID: Clinical Monitoring Intelligence Database, hypothyroidism monograph (2026), Aether Forge

## Follow-up

- Preventive visit in four months. Nine-month review with electrolytes, renin and TSH. Endocrinology review at one year. **S**
- Next scheduled visit 1948-08-17: periodic adult preventive visit. **S**
